Zev Schuman-Olivier, MD

Zev Schuman-Olivier, MD is the new Medical Director for Boston Area Team at WestBridge. He is ABPN board certified in adult psychiatry. He graduated from Tufts University School of Medicine with AOA honors. He received psychiatry training at Harvard Medical School, completing adult psychiatry residency at Cambridge Health Alliance, where he was chief resident for addiction services. He completed specialty fellowship training in addiction psychiatry at Harvard/Partners Health Care where he developed clinical specialty areas, including young adults with dual diagnosis and outpatient treatment of opioid dependence. He is trained to provide evidence-based therapies for addiction including motivational interviewing, cognitive-behavioral therapy, and dialectical behavior therapy. He was nationally recognized for his research on buprenorphine treatment for opioid dependence as the winner of the American Academy of Addiction Psychiatry Young Investigator Award. He currently has a prestigious Dupont-Warren research fellowship from the Harvard Medical School Department of Psychiatry. In addition, he is principal investigator on several grants, including an ongoing NIH-supported randomized controlled trial of mindfulness training vs. cognitive-behavioral therapy for smoking cessation, which is funded by the National Institute on Drug Abuse. He conducts lectures and trainings on the integration of mindfulness into addiction treatment and recovery programs.